Mario andres Guerrero Torres

Prof. Mario andres Guerrero Torres


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2025 in Journal of Periodontal & Implant Science
Verified
Journal Article
Open access
PDF file
NRNéstor Ríos-Osorio
Néstor Ríos-Osorio
LLLuisGabriel Ladino
LuisGabriel Ladino
MTMario andres Guerrero Torres
Mario andres Guerrero Torres
Ríos-Osorio N, et al. J Periodontal Implant Sci. 2025 Jan;55:e10. https://doi.org/10.5051/jpis.2402080104

28 October 2025 in Journal of Composites Science
Verified
Journal Article
Open access
PDF file
MMMariana Mutis
Mariana Mutis
MTMario andres Guerrero Torres
Mario andres Guerrero Torres
Sylvia María Villarreal-ArchilaSylvia María Villarreal-Archila
Sylvia María Villarreal-Archila
JNJairo Nuñez
Jairo Nuñez
Additive manufacturing (AM) is rapidly transforming clinical workflows in dentistry by enabling the customized, efficient, and digitally integrated production of dental devices. However, the existing literature lacks a process-oriented perspective on its technical and operational impact. This study aims to address this gap through a dual-phase analysis using the Input–Transformation–Output (ITO) framework, providing practical insights into the operational reconfiguration enabled by AM. The first phase examined materials, image acquisition methods, design and lamination software, printing technologies, and key parameters across each stage of the AM workflow. The second phase analyzed four clinical applications (dental models, crowns and bridges, occlusal splints, and surgical guides) supported by a structured fabrication protocol and scanning electron microscopy (SEM) of 18 resin samples to assess surface quality and process-related defects. In addition, for each application, a comparative process analysis with traditional workflows was conducted using ASME diagramming. The findings indicate that AM reduces cycle times, manual intervention, and supply chain reliance while enabling production models such as Make-to-Order (MTO) and Engineer-to-Order (ETO). Its integration also fosters decentralized, in-clinic manufacturing with enhanced autonomy, flexibility, and reduced lead times. Nonetheless, this study highlights persisting challenges, including post-processing quality control, training requirements, and cost-efficiency concerns in low-volume settings. A hybrid model combining AM with conventional methods emerges as a pragmatic strategy for clinical adoption.

Verified
Journal Article
Open access
PDF file
MTMario andres Guerrero Torres
Mario andres Guerrero Torres
SBSilvia Milena Becerra-Bayona
Silvia Milena Becerra-Bayona
MAMartha L. Arango-Rodríguez Martha L. Arango-Rodríguez
Martha L. Arango-Rodríguez Martha L. Arango-Rodríguez
ECEmilio A Cafferata
Emilio A Cafferata
Background: Guided Bone Regeneration (GBR) relies on barrier membranes, for which polylactic acid (PLA) and its copolymer poly(lactic-co-glycolic acid) (PLGA) are promising biodegradable polymers. However, their inherent hydrophobicity limits biological performance, and the evidence regarding how specific modifications affect key human cell types, particularly osteoblasts and fibroblasts, remains scattered. Methods: A systematic review was conducted to synthesize the in vitro evidence on the response of primary human osteoblasts and fibroblasts to polylactic acid-based materials. Following a pre-registered protocol (10.17605/OSF.IO/CE8KB), a comprehensive search was performed across four major databases, and the risk of bias in the included studies was assessed using an adapted OHAT tool. Results: Twenty-six studies were included, which showed that polylactic acid-based materials have limited bioactivity, and their modification significantly improves cellular responses. The incorporation of bioceramics and growth factors, or alterations in surface topography, notably enhanced osteogenic differentiation and mineralization in osteoblasts. For gingival fibroblasts, topographical modifications like micro-grooves guided cell alignment and modulated proliferation. Conclusions: Native polylactic acid-based materials display limited bioactivity. However, functionalization through bioceramics incorporation, growth factor delivery, and surface topographical modification is crucial for transforming them into bioactive scaffolds capable of achieving the dual biofunctionality required for successful GBR.

1 January 2025 in Journal of Periodontal & Implant Science
Verified
Journal Article
Open access
PDF file
NRNéstor Ríos-Osorio
Néstor Ríos-Osorio
MOMangriveth Orozco-Agudelo
Mangriveth Orozco-Agudelo
ICIván Cespedes-Moreno
Iván Cespedes-Moreno
MCMarcela Contreras-Ibarra
Marcela Contreras-Ibarra
MTMario andres Guerrero Torres
Mario andres Guerrero Torres
OJOscar Jiménez-Peña
Oscar Jiménez-Peña
Ríos-Osorio N, et al. J Periodontal Implant Sci. 2025 Aug;55:e31. https://doi.org/10.5051/jpis.2500260013

28 February 2026 in Restorative Dentistry & Endodontics
Verified
Journal Article
Open access
NRNéstor Ríos-Osorio
Néstor Ríos-Osorio
SBSandra Briñez-Rodríguez
Sandra Briñez-Rodríguez
DBDavid Betancur-Calle
David Betancur-Calle
MGMarggie Grajales
Marggie Grajales
ÓJÓscar Mauricio Jiménez-Peña
Óscar Mauricio Jiménez-Peña
RFRafael Fernández-Grisales
Rafael Fernández-Grisales
Objectives: This study aimed to assess the molecular and cellular mechanisms involved in the epithelial proliferation that leads to the transformation of periapical granulomas (PGs) into inflammatory radicular cysts (IRCs).Methods: A comprehensive search was conducted in three databases. Experimental, observational, or descriptive studies using human or animal tissue samples, or epithelial cell cultures that assessed the molecular and/or cellular mechanisms driving the proliferation of epithelial rests of Malassez and their role in the transformation of PGs into IRCs were included. The risk of bias and applicability of the included studies were assessed using the QUADAS-2.Results: Fourteen studies (including 399 samples) met the inclusion criteria for qualitative synthesis. The studies highlight the role of pro-inflammatory cytokines (IL-1β, IL-6), growth factors (EGF, KGF, TGF-β, and IGF), and signaling pathways (NF-κB, MAPK/ERK, PI3K/AKT, and Smad) in the progression of PG to IRC. Biomarkers of epithelial proliferation, such as Ki-67, PCNA, and CD34, are consistently associated with this process, while MMP-13 emerges as a key regulator of epithelial behavior and matrix remodeling.Conclusions: IRC development arises from a transition from homeostatic to pathological signaling, in which pro-inflammatory mediator levels inside the periapical chronic inflammation override regulatory checkpoints.

26 May 2026 in International Endodontic Journal
Verified
Journal Article
Open access
PDF file
NRNéstor Ríos‐Osorio
Néstor Ríos‐Osorio
JGJames Gutmann
James Gutmann
TBTatiana M. Botero
Tatiana M. Botero
NTNessrin Taha
Nessrin Taha
RFRafael Fernández‐Grisales
Rafael Fernández‐Grisales
JCJavier Caviedes-Buchelli
Javier Caviedes-Buchelli
Background: The transition from reversible to irreversible pulpitis remains inadequately defined at the molecular level. Current classifications rely largely on clinical symptoms rather than objective biological determinants, limiting diagnostic precision and therapeutic decision‐making. Objectives: To integrate current experimental and translational evidence positioning inflammasomes as central molecular decision‐making platforms in pulpal inflammation, and to propose a biologically grounded model in which inflammasome activation and supramolecular assembly define the threshold separating adaptive, reversible inflammation from irreversible pulpal damage, with direct clinical implications. Methods: A structured narrative review was conducted following a comprehensive literature search of PubMed/MEDLINE, Scopus, and Web of Science from inception to December 2025. Evidence derived from in vitro systems, in vivo animal models, and analyses of human inflamed pulpal tissues was synthesised to characterise inflammasome sensors, adaptor and effector components, regulatory checkpoints, downstream inflammatory outputs, and their relevance to pulpal disease progression. Results: Dental pulp cells express functional inflammasome sensors, including NLRP3, AIM2, and NLRP6, which respond to inflammatory, metabolic, and damage‐associated signals. Inflammasome activation follows a stepwise process of transcriptional priming and threshold‐dependent assembly. While NF‐κB– and type I interferon–mediated priming is adaptive and potentially reversible, ASC speck formation represents a molecular commitment point leading to caspase‐1 activation, gasdermin D cleavage, IL‐1β/IL‐18 maturation, and pyroptotic cell death. Mitochondrial dysfunction, cytosolic mtDNA release, sustained ion fluxes, P2X7 signalling, and loss of endogenous inhibitory regulators further amplify inflammasome activity, promoting self‐sustaining inflammatory circuits and progressive tissue breakdown. Conclusions: Pulpal inflammation should be understood not as a linear increase in microbial burden, but as a biological transition driven by inflammasome checkpoint failure. Irreversible ASC speck formation functions as a commitment switch that sustains caspase‐1 activation, gasdermin D–mediated pyroptosis, and self‐amplifying IL‐1β/IL‐18 signalling. Within the confined pulp environment, this feed‐forward inflammatory circuitry promotes neurovascular dysregulation and severe pain, ultimately becoming uncoupled from the initiating insult and incompatible with tissue recovery. Recognising Inflammasome activation (ASC speck formation) as a point of no return may refine diagnostic paradigms and help redefine the biological limits of vital pulp therapy.